microdosing glp 1 perimenopause reddit GLP-1s Explained Microdosing GLP-1s: Benefits for Menopause

The qualifying diagnoses (HFpEF, uncontrolled hypertension, CKD, pre-diabetes, prior MI, prior stroke, PAD) are the conditions where GLP-1 trials have shown direct benefit or strong biological plausibility for benefit

This study focused on the postprandial blood glucose changes in healthy humans by a systematic review and meta-analysis

Whether youre easing into a new medication or looking for a more pleasant way to meet your nutrition goals, these shakes can be a game changer

10.1002/anr3.12278 [DOI] [PMC free article] [PubMed] [Google Scholar] 12.Silveira SQ, da Silva LM, de Campos Vieira Abib A, de Moura DTH, de Moura EGH, Santos LB, Ho AM, et al

The short circulating half-life ( t 1/2 ) of native GLP-1 (1 minute) makes it unfit as a therapeutic agent, and longer-acting GLP-1RAs with half-lives ranging from 2.5 hours to more than a week have been developed for the treatment of both type 2 diabetes and obesity (Table 1) (18)

GLP-1 and Amylin in the Treatment of Obesity